Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
Thursday, June 11, 2009 - 10:21
in Health & Medicine
Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study.